Twitter | Search | |
UCLA Broad Stem Cell
Supporting innovation, excellence, and the highest ethical standards focused on taking stem cell discoveries from the lab to the patient. (RT≠endorsement)
546
Tweets
731
Following
1,172
Followers
Tweets
UCLA Broad Stem Cell retweeted
UCLA Health 4h
While are seen as important tools in potential new therapies for diabetes, Parkinson’s and heart disease, the FDA recommends that patients avoid stem cell that are not part of an approved . ➨
Reply Retweet Like
UCLA Broad Stem Cell retweeted
Geoff Lomax Apr 18
Stephanie Cherqui describes how ⁦⁩ funding is driving a treatment for
Reply Retweet Like
UCLA Broad Stem Cell Apr 18
Dr. Daniela Bota, a neuro-oncologist and co-director of the UCLA-UCI Alpha Stem Cell Clinic, discusses the risks of tourism at . Here are 4 things to look for in a stem cell clinical trial
Reply Retweet Like
UCLA Broad Stem Cell Apr 18
Stephanie Jackson, an oncology clinical nurse specialist , discusses the critical partnership with patients that is necessary for successful at
Reply Retweet Like
UCLA Broad Stem Cell Apr 18
Dr. Don Kohn presents his work developing gene therapy approaches for , and anemia at . As his final slide shows, it takes a village and significant resources to achieve scientific discoveries that may cure disease.
Reply Retweet Like
UCLA Broad Stem Cell retweeted
Geoff Lomax Apr 18
Don Kohn describes gene therapy for blood diseases in children
Reply Retweet Like
UCLA Broad Stem Cell Apr 17
Will do! Thank you for your continued advocacy, Yoni!
Reply Retweet Like
UCLA Broad Stem Cell Apr 17
Dr. Kohn developed a gene therapy for another form of this disease, ADA-SCID, that has cured 30 out of 30 babies to date. Learn more about that work here: cc:
Reply Retweet Like
UCLA Broad Stem Cell Apr 17
“It’s just nice to see another success for gene therapy,” Dr. Donald Kohn tells of the new treatment for SCID-X1, a form of severe combined immunodeficiency (AKA bubble baby disease), reported today in .
Reply Retweet Like
UCLA Broad Stem Cell retweeted
Englander Institute for Precision Medicine Apr 17
Don't miss today's SPORE Seminar, "Convergent Evolution to a Stem Cell Phenotype in Epithelial Cancers," by Owen Witte, M.D. of the Broad Stem Cell Research Center at UCLA () 4 PM today, Belfer Research Building, Room 204 A/B/C
Reply Retweet Like
UCLA Broad Stem Cell retweeted
CIRM Apr 15
How to choose a legitimate clinical trial and avoid a bogus one. Join CIRM for a Facebook Live “Ask the Stem Cell Team About Clinical Trials” event on Thursday, April 25th from noon till 1pm PDT.
Reply Retweet Like
UCLA Broad Stem Cell retweeted
DGSOM at UCLA Apr 12
UCLA’s Reza Ardehali, MD, PhD; Maureen A. Su, MD; and Siavash L. Kurdistani, MD, celebrate their induction into the American Society for Clinical Investigation during the AAP//APSA . ➨
Reply Retweet Like
UCLA Broad Stem Cell retweeted
CIRM Apr 9
Mending : the Past, Present & Future of Regenerative Medicine - sponsored conference helps patients trying to find a clinical trial and avoid a bogus life-threatening therapy
Reply Retweet Like
UCLA Broad Stem Cell retweeted
UCLA Health Apr 8
neurosurgeon Dr. Linda Liau invented a vaccine to save patients after her mother died of brain cancer. Watch her interview tonight at 9 pm PT on with
Reply Retweet Like
UCLA Broad Stem Cell retweeted
UCLA Jonsson Comprehensive Cancer Center Apr 2
Happening now: Dr. Antoni Ribas, President-Elect, discusses using combination therapies to overcome resistance to PD-1 blockade therapy.
Reply Retweet Like
UCLA Broad Stem Cell Mar 28
A huge congratulations to center member Dr. Antoni Ribas on being named President-Elect of the American Association for Cancer Research !
Reply Retweet Like
UCLA Broad Stem Cell retweeted
UCLA Dentistry Mar 21
affects nearly half of Americans ages 30 and older, and in its advanced stages, it could lead to early tooth loss or worse. New class of membranes, developed by may be a solution to gum disease and wound healing.
Reply Retweet Like
UCLA Broad Stem Cell retweeted
Cancer Cell Mar 19
Kislinger, Boutros & co Comprehensive proteomic analyses of localized, intermediate-risk prostate cancers reveal five proteomic subtypes with distinct clinical trajectories & develop multi-omic biomarkers with improved prognostic performance .
Reply Retweet Like
UCLA Broad Stem Cell retweeted
UCLA Health Mar 15
In a big leap from currently available CAR-T therapies, scientists developed a technique for getting into T cells that can attack . ➨
Reply Retweet Like
UCLA Broad Stem Cell retweeted
Kelsey C Martin Mar 12
is ranked No. 5 in Primary Care and No. 6 in Research, according to U.S. News and World Report. Thank you to each and every member of this exceptional community of physicians, scientists, students, trainees and staff.
Reply Retweet Like